A study to evaluate the effect of febuxostat in heart failure patients with hyperuricemia

A study to evaluate the effect of febuxostat in heart failure patients with hyperuricemia - A study to evaluate the effect of febuxostat in heart failure patients with hyperuricemia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021919

Enrollment

200

Registered

2016-04-15

Start date

2016-04-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure

Interventions

febuxostat,

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Heart failure patients with hyperuricemia

Exclusion criteria

Exclusion criteria: Patients with contraindication of febuxostat

Design outcomes

Primary

Measure	Time frame
To evaluate the effect of febuxostat, particularly on endothelial function, in heart failure patients with hyperuricemia	—

Secondary

Measure	Time frame
To evaluate the effect of febuxostat on heart failure biomarkers in heart failure patients with hyperuricemia	—

Countries

Japan

Contacts

Public ContactMinaguchi, Tabuchi Minaguchi, Tabuchi

Kochi Medical School Hospital Kochi Medical School Hospital

rinri21@kochi-u.ac.jp088-880-2352

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026